Literature DB >> 20522847

Clinical characteristics of fatalities due to influenza A (H1N1) virus in Mexico.

Germán Fajardo-Dolci1, Rafael Gutierrez-Vega, Heberto Arboleya-Casanova, Aremis Villalobos, Kate S Wilson, Sandra G García, Julio Sotelo, José A Córdova Villalobos, Claudia Díaz-Olavarrieta.   

Abstract

BACKGROUND: Mexico has experienced a disproportionate mortality burden due to the influenza A(HIN1) pandemic. A study was undertaken to investigate the sociodemographic and clinical characteristics of the first 100 patients who died from confirmed influenza A(H1N1).
METHODS: A clinical evaluation was made of the first 100 consecutive deaths of confirmed cases between 10 April and 28 May 2009 reported by the Federal Ministry of Health. Statistical analysis included disease frequencies and descriptive comparisons with national health data.
RESULTS: Most patients (60%) were aged 30-79 years, 53% were female and 40% were residents of Mexico City. On admission, 50% had one or more chronic medical conditions including metabolic syndrome (40%), cardiovascular disease (21%), diabetes (20%), hypertension (20%) and respiratory disease (8%). 38% of women and 26% of men were obese based on body mass index). The main clinical symptoms were fever (84%), cough (85%), dyspnoea (75%) and myalgia (30%). The frequency of all chronic diseases was higher in this sample than in the national statistics. Most (82%) developed symptoms before the Mexican government issued the influenza alert (24 April). Median hospital stay prior to death was 4 days (range 0-58).
CONCLUSIONS: Patients, mostly young adults, who died from A(HIN1) influenza had a high frequency of one or more chronic diseases upon admission. Most died shortly after the health authorities initiated national influenza control measures.

Entities:  

Mesh:

Year:  2010        PMID: 20522847     DOI: 10.1136/thx.2009.126953

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  9 in total

1.  Hospitalised patients with suspected 2009 H1N1 influenza A in a hospital in Norway, July - December 2009.

Authors:  Bjorn J Brandsaeter; Magnus Pillgram; Dag Berild; Harald Kjekshus; Anne-Marte B Kran; Bente M Bergersen
Journal:  BMC Infect Dis       Date:  2011-03-24       Impact factor: 3.090

2.  Fasting plasma glucose is an independent predictor for severity of H1N1 pneumonia.

Authors:  Wei Wang; Hong Chen; Qiang Li; Bo Qiu; Jiajun Wang; Xiwen Sun; Ying Xiang; Jinchao Zhang
Journal:  BMC Infect Dis       Date:  2011-04-21       Impact factor: 3.090

3.  Mortality from Pandemic Influenza A (H1N1) in Iran.

Authors:  M M Gouya; M Nabavi; M Soroush; A A Haghdoust; S Ghalehee; P Hemmati; M Nasr Dadras; M K Fallahzadeh; K B Lankarani
Journal:  Iran Red Crescent Med J       Date:  2011-10-01       Impact factor: 0.611

4.  Mortality amongst patients with influenza-associated severe acute respiratory illness, South Africa, 2009-2013.

Authors:  Cheryl Cohen; Jocelyn Moyes; Stefano Tempia; Michelle Groome; Sibongile Walaza; Marthi Pretorius; Halima Dawood; Meera Chhagan; Summaya Haffejee; Ebrahim Variava; Kathleen Kahn; Anne von Gottberg; Nicole Wolter; Adam L Cohen; Babatyi Malope-Kgokong; Marietjie Venter; Shabir A Madhi
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

5.  Potential New H1N1 Neuraminidase Inhibitors from Ferulic Acid and Vanillin: Molecular Modelling, Synthesis and in Vitro Assay.

Authors:  Maywan Hariono; Nurshariza Abdullah; K V Damodaran; Ezatul E Kamarulzaman; Nornisah Mohamed; Sharifah Syed Hassan; Shaharum Shamsuddin; Habibah A Wahab
Journal:  Sci Rep       Date:  2016-12-20       Impact factor: 4.379

6.  Prevalence of Diabetes in the 2009 Influenza A (H1N1) and the Middle East Respiratory Syndrome Coronavirus: A Systematic Review and Meta-Analysis.

Authors:  Alaa Badawi; Seung Gwan Ryoo
Journal:  J Public Health Res       Date:  2016-12-21

Review 7.  The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09.

Authors:  Chandini Raina MacIntyre; Abrar Ahmad Chughtai; Michelle Barnes; Iman Ridda; Holly Seale; Renin Toms; Anita Heywood
Journal:  BMC Infect Dis       Date:  2018-12-07       Impact factor: 3.090

8.  Molecular Docking Studies and Biological Evaluation of Berberine-Benzothiazole Derivatives as an Anti-Influenza Agent via Blocking of Neuraminidase.

Authors:  Manu Kumar; Sang-Min Chung; Ganuskh Enkhtaivan; Rahul V Patel; Han-Seung Shin; Bhupendra M Mistry
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 5.923

9.  Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China.

Authors:  Xiao Yu; Xiaodong Sun; Peng Cui; Hao Pan; Sheng Lin; Ruobing Han; Chenyan Jiang; Qiwen Fang; Dechuan Kong; Yiyi Zhu; Yaxu Zheng; Xiaohuan Gong; Wenjia Xiao; Shenghua Mao; Bihong Jin; Huanyu Wu; Chen Fu
Journal:  Transbound Emerg Dis       Date:  2020-05-13       Impact factor: 4.521

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.